Mankind Pharma rises 4% after Investec initiates coverage on the stock Posted by Able on September 19, 2024 Get link Facebook X Pinterest Email Other Apps Investec initiated coverage of the stock with a "buy" rating, forecasting an upside of 37.7% in 12 months. Comments
Comments
Post a Comment